Andrea Romano

ORCID: 0000-0002-5900-6883 · 38 papers in corpus
meta-analysis 2016
Archives of gynecology and obstetrics ·doi:10.1007/s00404-016-4244-1

PURPOSE: Hysteroscopic surgery is considered the gold standard for the minimal invasive treatment of many endouterine diseases such as endometrial polyps or submucous myomas. Recently, many studies have evaluated the effect of preoperative …

lab-animal 2013
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2013-2851

CONTEXT: Endometriosis affects 10% of the women before menopause and has important personal, professional, and societal economic burdens. Because current medical treatments are aimed at reducing the symptoms only, novel therapeutic targets …

other 2012
Human Reproduction ·doi:10.1093/humrep/des124

BACKGROUND: Paired-box 2 (Pax2) is involved in the development of the female genital tract and has been associated with endometrial pathologies. The expression of Pax2 is induced by epidermal growth factor (EGF) and estrogens. In the presen…

lab-animal 2012
PloS one ·doi:10.1371/journal.pone.0033241

Endometriosis is defined as the presence of endometrial tissue outside the uterus. It affects 10-15% of women during reproductive age and has a big personal and social impact due to chronic pelvic pain, subfertility, loss of work-hours and …

other 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.01.031

OBJECTIVE: To determine [1] expression levels of both DNA methyltransferases (DNMTs) and methyl-CpG-binding domain proteins (MBDs) in human endometrium throughout the menstrual cycle and in eutopic and ectopic endometrium of patients with e…

2011
lab-animal 2010
The American Journal of Pathology ·doi:10.2353/ajpath.2010.100026

Olfactomedin-4 (OLFM-4) is an extracellular matrix protein that is highly expressed in human endometrium. We have examined the regulation and function of OLFM-4 in normal endometrium and in cases of endometriosis and endometrial cancer. OLF…

other 2010
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.06.022
observational 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.10.041

The prevalence of the BLyS -817C>T polymorphic variant among women with either deep infiltrating endometriosis or adenomyosis compared with a group of gynecologic patients without symptomatic endometriosis and a group of healthy women was a…

2009
Molecular Endocrinology ·doi:10.1210/mend.23.2.9993

Context: substantial evidence suggests that the expression of steroid metabolizing enzymes in endometriosis is altered, turning the ectopic endometrium into a source of 17β-estradiol. However, whether these differences result in a net incre…

other 2008
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2008-2218

CONTEXT: substantial evidence suggests that the expression of steroid metabolizing enzymes in endometriosis is altered, turning the ectopic endometrium into a source of 17beta-estradiol. However, whether these differences result in a net in…

observational 2007
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719107303436

Deep infiltrating endometriosis is characterized by the presence of nodular lesions largely composed of fibromuscular tissue. Transforming growth factor beta 1 (TGF-beta1) is the cytokine most causatively associated with disorders character…

observational 2006
Human Reproduction ·doi:10.1093/humrep/del325

BACKGROUND: Alterations in the progesterone receptor (PR) are considered a risk factor for the development of endometriosis. In this study, the frequencies of the PROGINS and +331G/A polymorphisms of the PR gene were determined in deep infi…